1. Market performance and logical reasoning
Haineng Investment Consulting Yuan Songtao,Haineng Investment Consulting Wu Jian, Zhu Chao, Xu Xiyao, Pan Wenlong, Ye Hailin, Yuan Songtao, Wu Jian, Ouyang Xiaozhi, Zhao Xing, Huang Fei, Song Luyi, etc. "Today's closing performance, the Shanghai Composite Index fell 0.40% to close at 3199 points; the Shenzhen Component Index rose 0.17% to close at 11418 points; the ChiNext Index rose 0.87% to close at 2414 points. Today's differentiation performance of the two markets, The GEM led the rise and strengthened. In the afternoon, the Shanghai Composite Index turned red, but fell again. The GEM showed a large-scale increase in . The Shanghai Composite Index maintained fluctuations, and the pharmaceutical sectors in the market strengthened across the board. The market still rotated. The GEM strengthened, and the sentiment rebounded, and the funds were relatively active. The trading was relatively positive. There was a 10 billion transaction price on the market. The target hitting the daily limit. It also further showed that the funds were in a group, and the theme also began to try to lead the rise and lead the team, establish indicators, gather funds, and continue to promote the board. The block is upward, and the direction of the loss effect has weakened, but the real estate, semiconductor and other sectors on the market are weakening, so we still need to be cautious in choosing the market direction. The on-market sector has a rush of daily limit and will face differentiation tomorrow. By then, it is a knockout round to move to the front row of the sector to cope with the rhythm of differentiation.
Is Haineng Investment Consulting reliable for 1,980 yuan, is the stock recommended by Haineng Investment Consulting reliable, is Haineng Investment Consulting reliable for 1,980 yuan plus membership, is Haineng Investment Consulting reliable for 29,800 yuan, Haineng Investment Consulting reliable for 29,800 yuan, Haineng Investment Investment Consulting reliable for Taking the company's charging stock recommendations, from the perspective of index technology, the ChiNext continues to positive line upward, and the weight leads the rise. The sector also begins to perform, and the sentiment improves significantly. The sector's strengthening also begins to show a continuous money-making effect , attracting more funds to try to join the group, but instead contribute to the index. It is expected to continue the rebound performance in the future. However, the expectation is still swaying , which turns one step and three times back. After all, the expected probability of a big rise every day is low, but the upward trend has not changed, and it is still relatively happy. Looking at the trend of the Shanghai Composite Index, after the rebound, it showed fluctuations for two consecutive days. After the afternoon weight Kweichow Moutai , Wuliangye , etc. weakened, which had a great impact on the index, and there was also a seesaw effect in the market. Whoever leads the team will start to compete for funds. For example, whether it is the Chinese character or the direction of medicine, it is worth observing to judge the changes in the index.
, the bidding weights are obvious differentiated, and the news-stimulated ursodeoxycholic acid is stimulated by the news-stimulated abnormal movement , Science and Technology Innovation Board Xuantai Pharmaceutical One-line board, stocks such as Tong Pharmaceutical and Guangshengtang followed the performance, and yesterday's consumer retail and logistics direction continued to perform. Dongbai Group , Small Commodity City , Renrenle , etc. stepped out of the 2 board, and the logistics of Sanyangma and others led the rise.
Early trading, the Chinese medicine sector opened low and weakened, and the anti-viral fabric sector led the front line Strengthening, Ruyi Group went out of the 3 boards, and the recently active Anel continued to hit the daily limit, and the sector stocks followed. During the session, civil aviation, tourism composite liquid and lithium batteries performed in turn, and funds entered a rotation performance again, while real estate and Chinese characters weakened, Shenshenfang A fell to the daily limit, CNPC Capital plunged hit the daily limit, and the index also fell back for a while.
Chinese medicine sector strengthened in the afternoon, Shanghai Jiabao, Yiling Pharmaceutical continues to rise, driving the rebound of sector stocks and extending to pharmaceutical and biological sectors. The atmosphere in the market rose again, the Shanghai Composite Index once quickly turned red and rose, the pharmaceutical sector began to strengthen across the board, and the number of stocks hitting the daily limit continued to rise, such as Xinhua Pharmaceutical , Guizhou Bailing, the leader of the Chinese army Yiling Pharmaceutical, etc., went out of a strong counter-investment, the stocks in the new crown drug sector began to be active, the market and the market showed its unique appearance, the money-making effect also showed a recovery, the funds were actively active, and the volume was released. Beware of tomorrow's differentiation and rotation performance, and deal with it well.
2. market money-making effect atmosphere and strong stocks on the board
3. Market focus sectors and individual stocks listed
[Big consumption]:
In recent days, many places across the country have optimized and adjusted relevant measures for epidemic prevention and control. Shenyang, Shenzhen, Nanjing, Urumqi and other places have successively issued news that they will no longer check the negative nucleic acid test certificate by taking transportation and entering community supermarkets and other places. Dongwu Research Report pointed out that as the requirements for travel inspection nucleic acid testing are gradually relaxed, residents' travel willingness is expected to rebound, and travel consumption is expected to enter a substantial climbing stage.
sector echelon stocks: Dongbai Group, Small Commodity City, Renrenle, Shenzhen ChinaA
[Pharmaceutical]:
Relevant persons from the State Administration of Traditional Chinese Medicine said that the "14th Five-Year Plan" period is an important beginning for the new journey of comprehensively building a modern socialist country, and an important opportunity period for informatization innovation to lead the high-quality development of traditional Chinese medicine . However, the problems of unbalanced, uncoordinated and in-depth development of traditional Chinese medicine are still relatively prominent, and there is a big gap with the requirements of Digital China, Traditional Chinese Medicine inheritance, innovation and development, and national health informatization. There are major shortcomings and weaknesses in infrastructure, data applications, etc. The above-mentioned person pointed out that the next step will be to give full play to the initiative and enthusiasm of the central and local governments, improve the organization and implementation mechanism, and focus on consolidating the foundation for the development of informatization of traditional Chinese medicine, deepening digital convenience and benefiting services, strengthening the governance of traditional Chinese medicine data resources, and promoting the innovative application of traditional Chinese medicine data resources, providing strong support for promoting the modernization of traditional Chinese medicine, promoting the high-quality development of traditional Chinese medicine industry and industries, and better ensuring people's health.
sector echelon stocks: Xuantai Pharmaceutical, Xinhua Pharmaceutical, Yiling Pharmaceutical, Guizhou Bailing
IV, market capital offensive context
5, December 7 active hot money Dragon Tiger List
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-